Archean Chemical Industries Ltd is Rated Sell

Current Rating Overview

MarketsMOJO currently assigns Archean Chemical Industries Ltd a 'Sell' rating, reflecting a cautious stance on the stock. This rating was revised on 27 January 2026, when the company’s Mojo Score improved from 26 to 37, moving the grade from 'Strong Sell' to 'Sell'. Despite this improvement, the recommendation indicates that investors should remain wary due to ongoing challenges in the company’s financial and operational performance.

How the Stock Looks Today: Quality Assessment

As of 24 March 2026, Archean Chemical Industries maintains a good quality grade. This suggests that the company has a solid operational foundation and business model within the specialty chemicals sector. However, the quality grade alone does not offset other concerns. The company’s long-term growth trajectory has been disappointing, with net sales declining at an annualised rate of -7.69% over the past five years. Operating profit has contracted even more sharply, at -28.74% annually during the same period. These figures highlight persistent difficulties in expanding revenue and profitability.

Valuation Perspective

The stock is currently rated as very expensive on valuation metrics. As of today, the price-to-book value stands at 3.9, which is high relative to its return on equity (ROE) of 9%. This disparity indicates that the market price may not be fully justified by the company’s earnings power. Although the stock trades at a discount compared to its peers’ historical valuations, the expensive valuation grade signals limited upside potential without a meaningful improvement in fundamentals.

Financial Trend Analysis

The financial trend for Archean Chemical Industries is very negative. The latest data shows a decline in net sales by -8.55% in the December 2025 quarter, marking the eighth consecutive quarter of negative results. Profit after tax (PAT) for the latest quarter fell by -44.6% compared to the previous four-quarter average, underscoring the company’s ongoing profitability challenges. Additionally, interest expenses have surged by 75.31% over the last six months, reaching ₹9.94 crores, which further pressures net earnings. The return on capital employed (ROCE) for the half-year period is at a low 11.55%, reflecting inefficient capital utilisation.

Technical Outlook

From a technical standpoint, the stock is rated as sideways. This suggests that price movements have lacked clear direction recently, with no strong trend either upwards or downwards. The stock’s short-term returns show mixed performance: a 1-day gain of 0.53%, a 1-week rise of 7.84%, and a 3-month increase of 17.40%. However, the 6-month return is negative at -13.13%, indicating volatility and uncertainty in investor sentiment. Year-to-date, the stock has gained 10.37%, and over the past year, it has delivered a 13.13% return, despite the company’s deteriorating profit margins.

Investor Implications of the Current Rating

The 'Sell' rating reflects a cautious approach for investors considering Archean Chemical Industries Ltd. While the company shows some operational quality, the very expensive valuation combined with a negative financial trend and sideways technical movement suggests limited near-term upside. Investors should be aware that the company’s profitability and growth challenges remain significant headwinds. The rating advises that holding or accumulating the stock may carry elevated risk until there is clear evidence of a turnaround in financial performance and valuation alignment.

Stock Returns Snapshot

As of 24 March 2026, the stock’s returns present a mixed picture. The 1-year return stands at +13.13%, which is modest but positive. The 3-month return is stronger at +17.40%, indicating some recent momentum. However, the 6-month return is negative at -13.13%, reflecting volatility and underlying concerns. The year-to-date return of +10.37% shows some recovery since the start of the year. These returns must be weighed against the company’s declining profitability and rising interest costs, which may limit sustainable gains.

Sector and Market Context

Archean Chemical Industries operates within the specialty chemicals sector, a segment that often demands innovation and operational efficiency to maintain competitiveness. The company’s small-cap status means it is more susceptible to market volatility and sector-specific risks. Compared to broader market indices and sector peers, Archean’s valuation and financial trends lag behind, which contributes to the cautious rating. Investors should consider the company’s position relative to industry dynamics and macroeconomic factors affecting chemical manufacturing and demand.

Summary and Outlook

In summary, Archean Chemical Industries Ltd’s 'Sell' rating by MarketsMOJO reflects a comprehensive assessment of its current standing as of 24 March 2026. The company’s good quality is overshadowed by very expensive valuation, a very negative financial trend, and sideways technical signals. While the stock has shown some short-term gains, the persistent decline in sales and profits, coupled with rising interest costs, present significant challenges. Investors should approach the stock with caution and monitor for signs of operational turnaround or valuation correction before considering accumulation.

Key Metrics at a Glance (As of 24 March 2026)

• Mojo Score: 37.0 (Sell Grade)
• Market Capitalisation: Small Cap
• Net Sales Growth (5 years annualised): -7.69%
• Operating Profit Growth (5 years annualised): -28.74%
• Price to Book Value: 3.9
• Return on Equity (ROE): 9%
• Return on Capital Employed (ROCE): 11.55% (Half Year)
• Interest Expense Growth (6 months): +75.31%
• Profit After Tax (Quarterly): ₹23.64 crores, down -44.6%
• Stock Returns: 1Y +13.13%, 3M +17.40%, 6M -13.13%, YTD +10.37%

Investors should weigh these metrics carefully in the context of their portfolio strategy and risk tolerance.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →